home / stock / mdna / mdna articles

MDNA Articles, Medicenna Therapeutics Corp.

Stock Information
Company Name: Medicenna Therapeutics Corp.
Stock Symbol: MDNA
Market: NASDAQ
Menu
MDNA MDNA Quote MDNA Short MDNA News MDNA Articles MDNA Message Board
Get MDNA Alerts

News, Short Squeeze, Breakout and More Instantly...
Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp Survival Data in Recurrent Glioblastoma at the Society for Neuro-Oncology 2023 Annual Meeting | Benzinga

TORONTO and HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:MDNA, OTC:MDNAF), a clin...
Medicenna Presents Preclinical Data on MDNA113, its Targeted Metalloprotease Activated SuperKine (T-MASK) at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) | Benzinga

Company's T-MASK platform demonstrates ability to maximize anti-tumor efficacy and minimize systemic toxicity, and opportunities to explore b...

Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares jumped 232% to $3.36 in pre-market trading. United Therapeutics Corporation (N...

Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion. BIO-key International, Inc. (NASDAQ...
Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings | Benzinga

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Friday. Following the market opening Frida...

Medicenna Announces Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer's (SITC) | Benzinga

TORONTO and HOUSTON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or "the Company") ((NASDAQ, TSX:MDNA), a clinic...

Medicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officer | Benzinga

TORONTO and HOUSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (NASDAQ:MDNA, TSX:MDNA), a cl...
Medicenna to Present at the AACR Special Conference Cancer Research: Tumor Immunology and Immunotherapy | Benzinga

TORONTO and HOUSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or "the Company") ((NASDAQ, TSX:MDNA), a clini...

Medicenna to Participate at The H.C. Wainwright 25th Annual Global Investment Conference | Benzinga

TORONTO and HOUSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (NASDAQ:MDNA, TSX:MDNA), a c...

Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer | Benzinga

Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-scie...
Next 10